Skip to main content

Seventure Partners — Portfolio, Page 4

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

145
Companies
$2.2B
Total invested
$20.2M
Avg. check
48
Industries
Biotechnology 10Health Care 7Food and Beverage 4Biopharma 3SaaS 3Medical 3+42 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 7396 of 145
ErVimmune
January 2026

ErVimmune develops cancer vaccines and T cell therapies targeting cold tumors using AI-driven antigen discovery.

Biopharma · Lyon$19.9M Series A
Karmen
January 2026

Karmen is a fintech offering online non-dilutive funding for growth, working capital, and invoice factoring to digital businesses.

Finance · Paris$58.2M Debt Financing
The Sanctuary Group
January 2026

The Sanctuary Group provides aqua-cycling, indoor cycling, boxing bootcamp, yoga, dance cardio, HIIT workouts, and kids’ swim classes.

Fitness · Paris$5.5M Series Unknown
BIOMx
December 2025

BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.

Biotechnology · Ness Ziona$3.0M Post Ipo Equity
MaaT Pharma
November 2025

MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up.

Biotechnology · Lyon$10.6M Post Ipo Equity
Playse
October 2025

Playse is a platform that connects professional football instructors and parents to enroll kids in training sessions around country.

Fantasy Sports · Paris$3.5M Seed
Vertero
October 2025

Vertero Therapeutics is using cutting-edge research outside of the brain to treat neurodegenerative illnesses.

Biopharma · Woburn$20.0M Series D
Animab
July 2025

Animab is a biotechnology company specializing in proprietary technology that supports livestock health.

Biotechnology · Gent$11.8M Series B
ENTEROME
June 2025

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

Biopharma · Paris$19.0M Series Unknown
Eligo Bioscience
May 2025

Eligobiotics provides a new approach to explore, understand, and control bacterial ecosystems both in human and animals.

Biotechnology · Paris$5.0M Grant
Sekoia.io
April 2025

Sekoia.io is an intelligence driven SOC platform that enables security analysts to detect & respond threats in real time

Artificial Intelligence (AI) · Rennes$28.5M Series B
Flexvelop
March 2025

We buy your business equipment. You grow your company. Worry-free.

Commercial · Hamburg$43.4M Debt Financing
Seaweed Concept
February 2025

Seaweed Concept is a marine biotechnology company which supply the high quality ingredients from algae .

Biotechnology · Plumieux$2.1M Seed
Ekstere
February 2025

Ekstere facilitates selling and purchasing verified-quality used bicycles at a reasonable price.

E-Commerce · Paris$2.5M Series Unknown
Anybuddy
February 2025

Anybuddy connect Sportmen with sport Venues.

Events · Lille$2.1M Series Unknown
FIRE1
January 2025

FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.

Biotechnology · Dublin$120.0M Series B
bsport solution
December 2024

Bsport solution is a software platform for boutique fitness studios.

Fitness · Paris$31.4M Series B
one.bio
December 2024

one.bio is an emerging biotechnology spinout from UC Davis that creates ingredients for food and biopharmaceutical applications.

Biotechnology · Sacramento$27.0M Series A
Syroco
December 2024

Syroco is an innovation laboratory whose mission is to improve the efficiency of the transport and energy industries.

Environmental Engineering · Marseille$7.9M Series A
Dashbook
December 2024

Dashbook publishes the books that Internet users choose.

Books · Comberjon$2.1M Seed
Siit
November 2024

AI-powered Service Desk solution for IT and internal operations teams

Information Technology · Paris$5.0M Seed
Otoqi
October 2024

Otoqi is a vehicle delivery platform that develops connected services and logistics solutions for automotive professionals.

Automotive · Paris$10.9M Series B
La Vie
October 2024

La Vie is developing a 100% vegetable edible fat with the ambition of offering different types of vegetable meats.

Food and Beverage · Paris$25.2M Series Unknown
Standing Ovation
September 2024

Standing Ovation is a science to creating an animal-free, planet-friendly, vegan cheese that is still as dairy as the real thing.

Food and Beverage · Paris$4.2M Series A

Where Seventure Partners invests

Biotechnology10
Health Care7
Food and Beverage4
Biopharma3
SaaS3
Medical3

About Seventure Partners's portfolio

How many companies has Seventure Partners invested in?

Seventure Partners has invested in 145 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Seventure Partners invest in?

Seventure Partners's top investment sectors include Biotechnology, Health Care, Food and Beverage, Biopharma, SaaS. The firm invests across 48 different industry categories.

What is Seventure Partners's largest investment?

Among tracked funding rounds, FIRE1 received $120.0M in a Series B round. Seventure Partners's total known invested capital is $2.2B.

What is the average investment size for Seventure Partners?

Seventure Partners's average investment size is $20.2M across its portfolio of 145 companies.

What are Seventure Partners's most recent investments?

Recent Seventure Partners portfolio additions include ErVimmune, Karmen, The Sanctuary Group, BIOMx, MaaT Pharma. These companies were founded in 2020 or later.

Reach the founders behind these 145 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →